How much does a box of Bimekizumab cost?

Bimekizumab is a humanized IgG1 monoclonal antibody that selectively binds to IL-17A, IL-17F and IL-17AF cytokines and blocks their interaction with the IL-17RA/IL-17RC receptor complex. 1 Elevated levels of IL-17A and IL-17F are found in psoriatic lesions. Plaque psoriasis is red, scaly plaques with sharp edges and scaly tops that are usually silvery-white and is caused by an overactive immune system (autoimmune disease) as well as genetic and environmental factors.

Bimezumab is only available by prescription and should be used under the supervision of a physician experienced in diagnosing and treating psoriasis, psoriatic arthritis, and spinal arthritis. Bimezumab is available as an injection in a prefilled syringe or pen injector. It is administered as a subcutaneous injection. For plaque psoriasis and psoriatic arthritis associated with plaque psoriasis, patients receive two injections every four weeks for a total of 16 weeks. After that, injections are usually given every eight weeks. For isolated psoriatic arthritis and axial spondyloarthritis, patients receive injections every four weeks. If these conditions don't improve after 16 weeks, your doctor may decide to stop treatment. Once trained, patients can inject bimeclizumab themselves.

The generic drug Bimeizumab has not yet been launched in China, so it cannot be included in medical insurance. Domestic Huazhihe cannot purchase this drug through relevant channels. The European version of bimezumab original drug sold overseas, specifications160mg*2 per box may cost more than 40,000 yuan (the price may fluctuate due to the exchange rate). The price is still relatively high. There is currently no generic version of bimezumab produced and launched. For the specific price and drug information of this drug, please consult a medical consultant.